TCL Archive Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer August 30, 2013
TCL Archive Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding June 29, 1979
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1 March 4, 1988
